Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
Clinical Development Product Pipeline How Vaccines work Glossary Events


T cell
A type of white blood cell known as a lymphocyte that expresses an antigen binding complex (T cell receptor CD3 ) on the cell-surface. T cells bind processed antigen (antigenic peptides) presented by special cell surface (Major Histocompatibility Complex) molecules on antigen presenting cells or target cells.

T cell dependent/independent
T cell dependent antigens need immune recognition by both T- and B cells to produce an immune response. T cell independent antigens can directly stimulate B cells to produce specific antibody. However, T cell independent antigens are poorly immunogenic in infants and fail to induce immunological memory.

A measure of the strength of an antibody response e.g. the reciprocal of the last dilution of an antiserum capable of producing a specific effect (neutralizing antibody titer,etc.).

A poisonous substance. Toxins may be of biological origin (biotoxins). Biotoxin may be produced by microorganisms, fungi and higher plants.

The use of a vaccine to induce specific immunity to prevent (prophylactic vaccination) or to treat (therapeutic vaccination) a disease.

A preparation of antigenic material or nucleic acid used to induce immunity against disease causing microorganisms (or their products) or cancer cells.

A DNA molecule, typically a plasmid or a viral replicon, used to propagate inserted DNA fragments (e.g. genes) in a host cell.

 » Printversion

  » find


Baxter initiates clinical study with cell-based candidate H5N1 Pandemic Vaccine
» read more

Baxter to participate in development of cell-based vaccines for U.S. Department of Health and Human Services
» read more

Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
» read more

Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,